Credit Suisse Ag Abbott Laboratories Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Abbott Laboratories stock. As of the latest transaction made, Credit Suisse Ag holds 2,016,597 shares of ABT stock, worth $230 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

2,016,597

Previous 2,099,662 3.96%

Holding current value

$230 Million

Previous $231 Million 0.82%

% of portfolio

0.23%

Previous 0.23%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $9.1 Million - $10 Million	-83,065 Reduced 3.96%	2,016,597 $229 Million
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $58.5 Million - $71.6 Million	-648,639 Reduced 23.6%	2,099,662 $231 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $8.35 Million - $10 Million	87,370 Added 3.28%	2,748,301 $266 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $781,851 - $871,145	7,758 Added 0.29%	2,660,931 $290 Million
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $11.3 Million - $13.3 Million	116,350 Added 4.59%	2,653,173 $269 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $6.71 Million - $7.87 Million	70,563 Added 2.86%	2,536,823 $279 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $7.16 Million - $8.29 Million	-74,001 Reduced 2.91%	2,466,260 $239 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $10.3 Million - $12.4 Million	100,445 Added 4.12%	2,540,261 $276 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $6.12 Million - $7.46 Million	53,648 Added 2.25%	2,439,816 $289 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $3.43 Million - $4.2 Million	-29,686 Reduced 1.23%	2,386,168 $336 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $24 Million - $26.5 Million	205,708 Added 9.31%	2,415,854 $285 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $119 Million - $140 Million	-1,125,208 Reduced 33.74%	2,210,146 $259 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $81 Million - $95.4 Million	744,291 Added 28.73%	3,335,354 $400 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $1.77 Million - $1.93 Million	16,890 Added 0.66%	2,591,063 $284 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $358,129 - $434,921	3,908 Added 0.15%	2,574,173 $280 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $24.4 Million - $31.2 Million	-318,689 Reduced 11.03%	2,570,265 $235 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $13.2 Million - $19.3 Million	-209,716 Reduced 6.77%	2,888,954 $228 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $9.93 Million - $11 Million	126,424 Added 4.25%	3,098,670 $269 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $59 Million - $64 Million	720,791 Added 32.01%	2,972,246 $249 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $2.46 Million - $2.87 Million	33,711 Added 1.52%	2,251,455 $189 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $3.92 Million - $4.74 Million	59,211 Added 2.74%	2,217,744 $177 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $5.04 Million - $5.71 Million	-76,935 Reduced 3.44%	2,158,533 $156 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $21.8 Million - $26.3 Million	357,895 Added 19.06%	2,235,468 $164 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $10.8 Million - $11.9 Million	-188,065 Reduced 9.1%	1,877,573 $115 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $13.5 Million - $15.2 Million	-239,632 Reduced 10.39%	2,065,638 $124 Million
Q4 2017 Mar 14, 2018	BUY	$53.68 - $57.47 $536,800 - $574,700	10,000 Added 0.44%	2,305,270 $132 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $11.5 Million - $12.3 Million	-213,863 Reduced 8.52%	2,295,270 $131 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $21.7 Million - $24.2 Million	-451,513 Reduced 15.25%	2,509,133 $134 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,960,646	2,960,646 $144 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account